Trial Profile
Preventive effect of aliskiren on migraine complicated with hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jan 2019
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Candesartan cilexetil
- Indications Hypertension; Migraine
- Focus Therapeutic Use
- 07 Jan 2019 Status changed from recruiting to completed.
- 22 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 19 Sep 2011 New trial record